OP0099 Safety, tolerability and initial signs of efficacy of the fully human immunocytokine DEKAVIL (F8IL10): a novel therapeutic approach for rheumatoid arthritis

M Galeazzi; G Sebastiani; R Voll; J Wollenhaupt; O Viapiana; J Dudler; E Selvi; C Baldi; M Bardelli; B Bannert; S Finzel; C Specker; P Sarzi Puttini; F Bootz; D Neri; on behalf of the DEKAVIL Study Group

doi:10.1136/annrheumdis-2017-eular.4840

Article info

Oral Presentations

Progress in biological treatment of RA

OP0099 Safety, tolerability and initial signs of efficacy of the fully human immunocytokine DEKAVIL (F8IL10): a novel therapeutic approach for rheumatoid arthritis

Free

Authors

M Galeazzi 1University Hospital, Siena PubMed articles Google scholar articles
G Sebastiani 2San Camillo-Forlanini Hospital, Rome, Italy PubMed articles Google scholar articles
R Voll 3University Medical Center, Freiburg PubMed articles Google scholar articles
J Wollenhaupt 4Schoen-Klinik, Hamburg Eilbek, Germany PubMed articles Google scholar articles
O Viapiana 5University Hospital, Verona, Italy PubMed articles Google scholar articles
J Dudler 6Cantonal Hospital, Fribourg, Switzerland PubMed articles Google scholar articles
E Selvi 1University Hospital, Siena PubMed articles Google scholar articles
C Baldi 1University Hospital, Siena PubMed articles Google scholar articles
M Bardelli 1University Hospital, Siena PubMed articles Google scholar articles
B Bannert 3University Medical Center, Freiburg PubMed articles Google scholar articles
S Finzel 3University Medical Center, Freiburg PubMed articles Google scholar articles
C Specker 7University Hospital, Essen, Germany PubMed articles Google scholar articles
P Sarzi Puttini 8Luigi Sacco Hospital, Milan, Italy PubMed articles Google scholar articles
F Bootz 9Philochem AG, Otelfingen, Switzerland PubMed articles Google scholar articles
D Neri 10Philogen SpA, Siena, Italy PubMed articles Google scholar articles
on behalf of the DEKAVIL Study Group
Google scholar articles

Citation

Galeazzi M, Sebastiani G, Voll R, et al

OP0099 Safety, tolerability and initial signs of efficacy of the fully human immunocytokine DEKAVIL (F8IL10): a novel therapeutic approach for rheumatoid arthritis

Annals of the Rheumatic Diseases 2017;76:92-93.

Publication history

First published June 15, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password